Drugs / Piperacillin/tazobactam
last change Mar 2023 re-read 2 minutes ago

Piperacillin/tazobactam

Developed for
bacterial infectious disease
Investigated by
Sara Thønnings

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03108690 Oct 2017 → Mar 2023 bacterial infectious disease Sara Thønnings Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Piperacillin/tazobactam Piperacillin/tazobactamNCT03108690